By Nev Zubcevik, DO
Chief Medical Officer
Electrome is pioneering brain-focused bioelectric medicine by using targeted electromagnetic stimulation to restore disrupted neural circuits, offering new hope for conditions like concussion, stroke, dementia, and depression.
Introduction
As bioelectric medicine advances from theory into mainstream clinical practice, nowhere is its promise more urgent than in brain health. Concussions, strokes, and neurodegenerative disorders remain devastating and costly, yet the brain is fundamentally an electrical system. By restoring disrupted bioelectric patterns, we may offer new hope to millions living with injury or decline.
Bioelectricity: The brain’s hidden code
From the firing of a neuron to the consolidation of a memory, the brain’s functions are orchestrated through electrical signals. When trauma or disease disrupts these patterns through inflammation, vascular injury, or synaptic decay, symptoms appear: memory loss, headaches, mood dysregulation, paralysis. Unlike many pharmaceuticals, bioelectric modulation targets the signaling itself, addressing root dysfunction rather than downstream effects.
Reconnecting the injured brain
At Electrome and partner institutions, teams are pioneering pulsed electromagnetic field (PEMF) therapies to accelerate neural repair and reduce neuroinflammation. Concussion and traumatic brain injury therapies have shown PEMF can stabilize the blood-brain barrier, reduce edema, and normalize disrupted circuits. Stroke recovery protocols demonstrate that by enhancing BDNF and IGF-1, stimulation promotes neuroplasticity and aids rehabilitation of movement and speech. In dementia and Alzheimer’s disease, frequency-tuned fields can improve default mode network function and memory consolidation, reducing cognitive decline. Neuromodulation approaches are also showing promise in depression and PTSD by regulating overactive fear circuits and strengthening resilience. Erik Nilsen PhD, CTO of Electrome states, “The brain isn’t just a chemical organ. It’s an electrical system. The future of treating brain injury and cognitive decline may lie not in pills, but in patterns.”
Clinical impact and emerging data
At Mass General, Dr. Emiliano Santarnecchi showed that colleagues showed that one-hour administration of 40-Hz tACS improved memory in older adults at risk for Alzheimer’s (1).
Education and the next generation of providers
As with other areas of bioelectric medicine, education is essential. Electrome partners with teaching hospitals and neurology programs to train clinicians in brain-focused bioelectronic interventions, preparing a workforce skilled in deploying these therapies in acute and outpatient settings.
Bioelectric medicine in public policy and population health
With global costs of dementia projected to exceed $2 trillion annually, scalable bioelectric interventions could reshape public health strategies. Portable, non-invasive systems offer treatment options for both advanced hospital centers and under-resourced communities, reducing long-term dependence on pharmaceuticals (2).
Research frontiers and unresolved questions
Among the emerging research questions in brain-focused bioelectric medicine are: How can PEMF waveforms be optimized for different neurological conditions? Can adaptive, AI-driven stimulation predict and prevent episodes of cognitive decline? To what extent can bioelectric modulation enhance memory and executive function in healthy individuals? What safeguards are needed to ensure privacy, safety, and equitable access to neuroelectric technologies?
Electrome actively funds and collaborates on studies in these domains, sharing data with academic and industry partners to accelerate progress.
The road ahead
The near future promises adaptive bioelectric devices integrated with cloud data and AI to personalize signals in real time. Our patented technology merges electrophysiology with digital health, Electrome envisions a world where brain recovery and preservation are guided by dynamic, precise, and patient-centered electroceuticals.
References
- Santarnecchi, E., et al. (2022). Frequency-tuned transcranial stimulation improves memory in older adults. Sci Transl Med, 14(630): eabe8620. doi:10.1126/scitranslmed.abe8620
- https://www.globalpolicyjournal.com/blog/29/09/2017/dementia-set-become-2-trillion-global-crisis-heres-why#:~:text=1.,which%20is%20delivered%20by%20women.